Macmillan Coffee Morning
On September 27th between 11am and 1pm Airthrie will be taking part in the Macmillan Coffee Morning to help raise some money for Macmillan Cancer support. Macmillan cancer support provide invaluable support to individuals who are affected by cancer and we would like to help by contributing a donation on behalf of Airthrie and all those involved. Residents family and friends are encouraged to attend.
Airthrie 3 E’s
At Airthrie we aim to promote the 3 E’s; Education, Employment and Encouragement.
One resident has been attending college weekly and Airthrie was extremely proud when this resident achieved an outstanding achievement award at the College awards night. Furthermore we have also supported all residents who have chosen to attend education to enrol for courses starting in September.
Another area we like to encourage our residents to pursue is Employment, going to work is an ordinary part of many peoples daily routines however some people may find it difficult to get access to work which is why at Airthrie we actively encourage and assist our Residents with gaining employment either paid or voluntary. One resident has been working in a local charity shop for the past couple of years and has gained valuable experience in customer service and has also gained personal skills such as timekeeping, travel independence and an increase in confidence.
Alzheimer’s disease is the most common cause of dementia with around 6 in every 10 people with dementia being affected by it which is why its important that it is diagnosed early, Researchers at the Washington University School of Medicine in St Louis, Missouri, US have been looking into a blood test that can detect signs of Alzheimer’s up to 20 years before the disease will start affecting an individual by measuring levels of the protein amyloid beta which is an indicator of Alzheimer’s and then combining this with two other risk factors of Age and genetic variant. This new blood test is much cheaper than the current PET brain scan and is simpler. Randall Bateman, a leading professor of neurology stated that “Right now we screen people for clinical trials with brain scans, which is time-consuming and expensive, and enrolling participants takes years, But with a blood test, we could potentially screen thousands of people a month. That means we can more efficiently enrol participants in clinical trials, which will help us find treatments faster.”